<?xml version="1.0" encoding="UTF-8"?>
<mods
	xmlns="http://www.loc.gov/mods/v3"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	version="3.7"
	xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
	<titleInfo>
		<title>
			Engineering Escherichia coli to produce and secrete colicins for rapid and selective biofilm cell killing
		</title>
	</titleInfo>
	<name>
		<namePart>Jin, Xing</namePart>
		<role>
			<roleTerm authority="marcrelator" type="text">Creator</roleTerm>
		</role>
	</name>
	<name>
		<namePart>An, Sungjun</namePart>
		<role>
			<roleTerm authority="marcrelator" type="text">Creator</roleTerm>
		</role>
	</name>
	<name>
		<namePart>Kightlinger, Weston</namePart>
		<role>
			<roleTerm authority="marcrelator" type="text">Creator</roleTerm>
		</role>
	</name>
	<name>
		<namePart>Zhou, Jiacheng</namePart>
		<role>
			<roleTerm authority="marcrelator" type="text">Creator</roleTerm>
		</role>
	</name>
	<name>
		<namePart>Hong, Seok Hoon</namePart>
		<role>
			<roleTerm authority="marcrelator" type="text">Creator</roleTerm>
		</role>
		<description>Faculty</description>
		<affiliation>shong26@iit.edu</affiliation>
		<nameIdentifier>https://orcid.org/0000-0003-2401-6368</nameIdentifier>
	</name>
	<name type="corporate">
		<namePart>ChBE / Chemical and Biological Engineering</namePart>
		<affiliation>Illinois Institute of Technology</affiliation>
		<role>
			<roleTerm type="text">Affiliated department</roleTerm>
		</role>
	</name>
	<subject>
		<topic>Biological Engineering</topic>
	</subject>
	<subject>
		<topic>Biotechnology</topic>
	</subject>
	<originInfo>
		<dateCreated encoding="w3cdtf" keyDate="yes">2021</dateCreated>
		<dateIssued encoding="w3cdtf" />
	</originInfo>
	<abstract
		>Bacterial biofilms are associated with chronic infectious diseases and are highly resistant to conventional
		antibiotics. Antimicrobial bacteriocins are alternatives to conventional antibiotics and are characterized by
		unique cell-killing mechanisms, including pore formation on cell membranes, nuclease activity, and cell wall
		synthesis inhibition. Here, we used cell-free protein synthesis to rapidly evaluate the antibiofilm activities
		of colicins E1, E2, and E3. We found that E2 (with DNase activity) most effectively killed target biofilm cells
		(i.e., the K361 strain) while leaving nontargeted biofilms intact. We then engineered probiotic Escherichia coli
		microorganisms with genetic circuits to controllably synthesize and secrete colicin E2, which successfully
		inhibited biofilms and killed preformed indicator biofilms. Our findings suggest that colicins rapidly and
		selectively kill target biofilm cells in multispecies biofilms and demonstrate the potential of using
		microorganisms engineered to produce antimicrobial colicin proteins as live therapeutic strategies to treat
		biofilm-associated infections.</abstract
	>
	<note type="funding">NIH-R15AI130988</note>
	<typeOfResource authority="aat" valueURI="http://vocab.getty.edu/aat/300048715">Article</typeOfResource>
	<language>
		<languageTerm type="code" authority="iso639-2b">en</languageTerm>
	</language>
	<relatedItem type="otherFormat">
		<identifier>https://doi.org/10.1002/aic.17466</identifier>
	</relatedItem>
	<accessCondition type="useAndReproduction" displayLabel="cc">Creative Commons Attribution (CC BY)</accessCondition>
	<accessCondition type="useAndReproduction" displayLabel="ccURI"
		>http://creativecommons.org/licenses/by/4.0/</accessCondition
	>
	<accessCondition type="restrictionOnAccess">Open Access</accessCondition>
	<recordInfo>
		<languageOfCataloging>
			<languageTerm authority="iso639-2b" type="code">eng</languageTerm>
		</languageOfCataloging>
	</recordInfo>
	<identifier type="hdl">http://hdl.handle.net/10560/islandora:1012026</identifier></mods
>
